INNATE PHARMA
Innate Pharma S.A. is a biopharmaceutical company developing first-in-class immunotherapy drug candidates for cancer and inflammatory diseases. The Company specializes in the development of novel monoclonal antibodies targeting receptors and pathways controlling the activation of innate immunity cells. Its innovative approaches have led to licensing agreements with Novo Nordisk A/S and Bristol-Myers Squibb.
INNATE PHARMA
Industry:
Biopharma Biotechnology Clinical Trials Medical Pharmaceutical
Founded:
1999-01-01
Address:
Marseille, Provence-Alpes-Cote D'Azur, France
Country:
France
Website Url:
http://www.innate-pharma.com
Total Employee:
51+
Status:
Active
Contact:
+33 (0)4 30 30 30 30
Total Funding:
201.1 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics Google Tag Manager Google Universal Analytics Font Awesome Domain Not Resolving Global Site Tag
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Immutep
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
BNP Paribas
BNP Paribas investment in Post-IPO Debt - Innate Pharma
Societe Generale
Societe Generale investment in Post-IPO Debt - Innate Pharma
AstraZeneca
AstraZeneca investment in Corporate Round - Innate Pharma
QVT Financial
QVT Financial investment in Post-IPO Equity - Innate Pharma
Redmile Group
Redmile Group investment in Post-IPO Equity - Innate Pharma
Ardian
Ardian investment in Series C - Innate Pharma
Ace Capital Partners
Ace Capital Partners investment in Series C - Innate Pharma
NIF SMBC Ventures
NIF SMBC Ventures investment in Series C - Innate Pharma
Novo Nordisk
Novo Nordisk investment in Series C - Innate Pharma
Akka Venture
Akka Venture investment in Series C - Innate Pharma
Key Employee Changes
| Date | New article |
|---|---|
| 2020-07-16 | Innate Pharma announces the appointment of Joyson Karakunnel, MD, MSC, FACP as Chief Medical Officer |
Official Site Inspections
http://www.innate-pharma.com Semrush global rank: 1.64 M Semrush visits lastest month: 15.16 K
Unable to get host informations!!!
